Proto Labs Inc: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Feb 26, 2020 and accepted by EDGAR at Feb 26, 2020, 11:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $458.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $223.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $235.3m | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $32.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $79.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $17.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2019-01-01 to 2019-12-31 | $63.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $2.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $2.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 27,049,423 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $116.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $62.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2019-01-01 to 2019-12-31 | $33.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-31 | $125.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $236.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $673.7m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $47.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $87.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-12-31 | $585.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-20-003547. Last ingested by Listed: Oct 29, 2026, 14:32 ET. Listed shows no prices and gives no investment advice.